Detailed Information on Publication Record
2021
CBD is not converted to THC in rats: A framework interpretation and discussion
VACEK, Jan, Barbora PAPOUSKOVA, Hana HOLCOVÁ POLANSKÁ, Kateřina HÖNIGOVÁ, Jan STORCH et. al.Basic information
Original name
CBD is not converted to THC in rats: A framework interpretation and discussion
Authors
VACEK, Jan (203 Czech Republic, guarantor), Barbora PAPOUSKOVA (203 Czech Republic), Hana HOLCOVÁ POLANSKÁ (203 Czech Republic, belonging to the institution), Kateřina HÖNIGOVÁ (203 Czech Republic, belonging to the institution), Jan STORCH (203 Czech Republic), Petr BABULA (203 Czech Republic, belonging to the institution) and Michal MASAŘÍK (203 Czech Republic, belonging to the institution)
Edition
European Neuropsychopharmacology, Amsterdam, Elsevier, 2021, 0924-977X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 5.415
RIV identification code
RIV/00216224:14110/21:00123918
Organization unit
Faculty of Medicine
UT WoS
000688393100016
Keywords in English
CBD; THC; rats
Tags
Tags
International impact, Reviewed
Změněno: 2/5/2022 14:19, Mgr. Tereza Miškechová
Abstract
V originále
Cannabidiol (CBD) is a non-psychotropic exogenous cannabinoid that is an active component in a number of topical and oral preparations. The pharmacological potential of CBD is determined by its anti-inflammatory and immuno- or neuromodulatory activities. This natural terpenoid is widely used today, and therefore more attention is now paid to examining its safety after the administration of high doses (Epidiolex) and also after low-dose chronic exposure, e.g. in the form of food supplements. CBD is therefore a molecule that has recently gained a great deal of scientific interest, both at the level of basic research and industrial development.